Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding

Journal of Viral Hepatitis

Volumn 22, Issue 3, 2015, Pages 289-296

  Pirillo, M F ^a   Scarcella, P ^b   Andreotti, M ^a   Jere, H ^c   Buonomo, E ^b   Sagno, J B ^c   Amici, R ^a   Mancini, M G ^a   Leone, P ^a   Ceffa, S ^d   Mancinelli, S ^b   Marazzi, M C ^e   Vella, S ^a   Palombi, L ^b   Giuliano, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c DREAM Program   (Malawi)

^d DREAM Program   (Italy)

^e LUMSA UNIVERSITY   (Italy)

Author keywords

Africa; breastfeeding; hepatitis B virus; HIV; lamivudine; perinatal transmission

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CHILD; FEMALE; GESTATIONAL AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; MOTHER; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; VERTICAL TRANSMISSION; VIRUS REPLICATION; ADVERSE EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MALE; RISK FACTOR; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; CHILD; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; MALE; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84923082846     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12301     Document Type: Article

References (28)

1. Hoffmann CJ, Thio CL,. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007; 7: 402-409.
2. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J,. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999; 58: 111-115.
3. Oshitani H, Kasolo FC, Mpabalwani M, et al,. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996; 90: 235-236.
4. Andersson MI, Maponga TG, Ijaz S, et al,. High HBV viral load in HIV-infected pregnant women at a tertiary hospital, South Africa. J Acquir Immune Defic Syndr 2012; 60: e111-e112.
5. Hyams KC,. Risks of chronicity following hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992-1000.
6. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2013 global summary. Available at: http://apps.who.int/immunization-monitoring/globalsummary (accessed 16 September 2013).
7. Plitt SS, Somily AM, Singh AE,. Outcomes from a Canadian public health prenatal screening program for hepatitis B:1997-2004. Can J Public Health 2007; 98: 194-197.
8. Ekra D, Herbinger KH, Konate S, et al,. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire. Vaccine 2008; 26: 2753-2761.
9. Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, et al,. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. J Clin Virol 2013; 58: 415-421.
10. Xu WM, Cui YT, Wang L, et al,. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103.
11. Chen X, Chen J, Wen J, et al,. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus. PLoS ONE 2013; 8: e55303.
12. Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS,. Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr 1993; 17: 207-210.
13. de Oliveira PR, Yamamoto AY, de Souza CB, et al,. Hepatitis B viral markers in banked human milk before and after Holder pasteurization. J Clin Virol 2009; 45: 281-284.
14. Giuliano M, Andreotti M, Liotta G, et al,. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery. PLoS ONE 2013; 8: e68950.
15. Palombi L, Pirillo MF, Andreotti M, et al,. Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety. Antiv Ther 2012; 17: 1511-1519.
16. Chasela CS, Kourtis AP, Wall P, et al,. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol 2014; 60: 508-14.
17. Plaza Z, Aguilera A, Mena A, et al,. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B. AIDS 2013; 27: 2219-2224.
18. Galluzzo C, Liotta G, Andreotti M, et al,. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi. J Med Virol 2012; 84: 1553-1557.
19. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html (accessed 16 September 2013).
20. Shi Z, Yang Y, Wang H, et al,. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med 2011; 165: 837-846.
21. Zheng Y, Lu Y, Ye Q, et al,. Should chronic hepatitis B mothers breastfeed? a meta analysis. BMC Public Health 2011; 11: 502.
22. Singh AE, Plitt SS, Osiowy C, et al,. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011; 18: 468-473.
23. Shao ZJ, Zhang L, Xu JQ, et al,. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011; 83: 791-795.
24. Candotti D, Danso K, Allain JP,. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol 2007; 88: 2686-2695.
25. Li F, Wang Q, Zhang L, et al,. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China. Vaccine 2012; 30: 7118-7122.
26. Wen WH, Chang MH, Zhao LL, et al,. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013; 59: 24-30.
27. Boot HJ, Hahné S, Cremer J, Wong A, Boland G, van Loon AM,. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. J Viral Hepat 2010; 17: 872-878.
28. Roberton DM, Marshall H, Dinan L, Boros C, Gold M,. Developmental immunology and vaccines: immune responses to vaccines in premature infants. Exper Rev Vaccines 2004; 3: 343-347.